BRIEF-Pacira Announces FDA Approval Of Supplemental New Drug Application For Exparel As A Nerve Block To Produce Regional Analgesia

* PACIRA ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR EXPAREL® AS A NERVE BLOCK TO PRODUCE REGIONAL ANALGESIA Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.